HHS funds vaccine candidates for Marburg, Sudan ebolavirus
The Department of Health and Human Services yesterday awarded $20.5 million to develop vaccine candidates for Marburg virus and Sudan ebolavirus, which are in the same family of viruses as the Ebola virus outbreak in the Democratic Republic of the Congo. The last outbreaks of Marburg virus and Sudan ebolavirus were in Uganda, in 2017 and 2012, respectively. The Sabin Vaccine Institute will conduct nonclinical studies and complete manufacturing activities to advance the development of the vaccine candidates under a contract with HHS’s Biomedical Advanced Research and Development Authority. BARDA also is helping to develop and procure vaccines, therapeutics and diagnostics for the Ebola strain circulating in the Congo.
Related News Articles
Headline
The American College of Cardiology, American Heart Association and nine other medical associations March 13 released updated guidelines on managing cholesterol…
Headline
A report published March 2 by the American Cancer Society found that colorectal cancer rates among adults 65 and older continue to decline while rates for…
Headline
An American Heart Association study published Feb. 25 found that 6 in 10 U.S. women are projected to develop a form of cardiovascular disease by 2050. The…
Headline
A JAMA study released Jan. 22 found that colorectal cancer is the leading cause of cancer deaths in people under age 50. The study examined cancer mortality in…
Headline
(Updated Jan. 23) A measles outbreak in South Carolina has reached 700 cases, the state’s Department of Public Health reported. The outbreak, initially…
Headline
The five-year survival rate for all cancers in the U.S. has reached 70% for the first time, according to a report published Jan. 13 by the American Cancer…